Recommendations for marketing approval by the European Medicine
Agency's Committee for Medicinal Products for Human Use (CHMP) are
normally endorsed by the European Commission within a couple of
Avastin, which is already approved in Europe to treat advanced
stages of breast cancer, colorectal cancer, non-small cell lung
cancer, kidney cancer and ovarian cancer, was Roche's biggest seller
last year with sales of 6.25 billion Swiss francs ($7 billion).
($1 = 0.8946 Swiss Francs)
(Reporting by Caroline Copley)
[to top of second column]
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.